NCT06979596 2026-04-13
OMAHA-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
Clinical Trials
10 trialsNCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
NCT06671548 2026-02-02
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT06998758 2025-12-12
MATRIX
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Recruiting
NCT05316467 2025-08-11
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Fudan University
Phase 2/3 Recruiting
NCT05247268 2025-04-06
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Fudan University
Phase 2 Recruiting
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT05913427 2024-08-01
PESETA
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2 Recruiting
NCT06500234 2024-07-15
Nutrition Impact on Immunotherapy of Cancer
Qingdao Central Hospital
Phase 3 Recruiting
NCT06417736 2024-05-16
Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting